AS-Pemetrexed

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Pemetrexed disodium hemipentahydrate 604.12mg equivalent to pemetrexed 500 mg

Available from:

Viatris Limited

INN (International Name):

Pemetrexed disodium hemipentahydrate 604.12 mg (equivalent to pemetrexed 500 mg)

Dosage:

500 mg

Pharmaceutical form:

Powder for infusion

Composition:

Active: Pemetrexed disodium hemipentahydrate 604.12mg equivalent to pemetrexed 500 mg Excipient: Hydrochloric acid Mannitol Sodium hydroxide

Units in package:

Vial, glass, single dose, 50 mL Ph. Eur. Type 1 with bromobutyl rubber stopper and Al flip-off seal, 1 dose unit

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Huzhou Zhan Wang Pharmaceutical Co., Ltd.

Therapeutic indications:

Malignant Pleural Mesothelioma Pemetrexed infusion is indicated for the treatment of patients with malignant pleural mesothelioma in combination with cisplatin.

Product summary:

Package - Contents - Shelf Life: Vial, glass, single dose, 50 mL Ph. Eur. Type 1 with bromobutyl rubber stopper and Al flip-off seal - 1 dose units - 24 months from date of manufacture stored at or below 25°C 24 hours reconstituted stored at or below 25°C. or at 2 - 8°C

Authorization date:

2012-06-14